Table 3.

Risk of Hematological Malignancies among Individuals with AUDs by Age at Identification.

Disease	< 40				40-60				60 +
	O	SIR	95% CI		O	SIR	95% CI		O	SIR	95% CI
Non-Hodgkin lymphoma	150	0.97	0.82	1.13	420	0.72	0.65	0.79	371	0.53	0.47	0.58
Diffuse large B cell	28	1.34	0.89	1.94	68	0.96	0.75	1.22	35	0.57	0.40	0.79
Follicular	9	0.93	0.42	1.77	34	0.77	0.53	1.08	19	0.59	0.36	0.93
Hodgkin disease	102	0.92	0.75	1.11	97	0.73	0.59	0.89	26	0.36	0.23	0.52
Mixed cellularity classic	9	1.05	0.48	2.00	7	0.95	0.38	1.97	2	0.49	0.05	1.82
Nodular sclerosis classic	44	1.10	0.80	1.47	19	1.20	0.72	1.88	7	1.23	0.49	2.56
Myeloma	15	0.98	0.55	1.62	104	0.77	0.63	0.94	77	0.34	0.27	0.43
Leukemia	120	0.61	0.50	0.72	160	0.55	0.47	0.65	113	0.40	0.33	0.48
Acute lymphatic leukemia	59	0.62	0.47	0.80	12	0.37	0.19	0.64	1	0.06	0.00	0.37
Acute myeloid leukemia	20	0.57	0.35	0.88	25	0.29	0.19	0.43	18	0.19	0.11	0.30
Chronic myeloid leukemia	19	0.80	0.48	1.25	26	0.49	0.32	0.72	18	0.45	0.26	0.71
All	387	0.81	0.73	0.89	781	0.68	0.64	0.73	587	0.46	0.42	0.49

O, observed number of cases; SIR, standardized incidence ratio; CI, confidence interval.

Bold type, 95% CI does not include 1.00.